Drawing for ANGION

USPTO serial 88782784

ANGION

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SNABB, SANDRA MARIE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ANGION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sara M. Bauer

Sara M. Bauer CHOATE HALL & STEWART LLPTWO INTERNATIONAL PLACEBOSTON, MA 02110UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Small molecule therapeutic pharmaceuticals for the treatment, alleviation and prevention of acute organ injuries and fibrotic diseases; pharmaceutical and biological preparations for the treatment, alleviation and prevention of heart conditions, brain conditions, kidney conditions, and liver conditions; pharmaceutical and biological preparations for use in the treatment, alleviation and prevention of ischemic conditions; pharmaceutical and biological preparations for use in the treatment, alleviation and prevention of fibrosis; pharmaceutical and biological preparations for use in the treatment, alleviation and prevention of autoimmune diseases; pharmaceutical and biological preparations for use in the treatment, alleviation and prevention of delayed graft function and acute kidney injuryACTIVE—
009Downloadable electronic publications in the nature of books, magazines, and brochures in the field of scientific research on heart conditions, brain conditions, kidney conditions, and liver conditions; downloadable electronic publications in the nature of books, magazines, and brochures in the field of scientific research on ischemic conditions, fibrosis, autoimmune diseases, organ transplantation; downloadable electronic publications in the nature of books, magazines, and brochures in the field of scientific research on acute organ injuriesACTIVE—
041Providing a website featuring non-downloadable electronic publications in the nature of books, magazines, and brochures in the field of scientific research on heart conditions, brain conditions, kidney conditions, and liver conditions; providing a website featuring non-downloadable electronic publications in the nature of books, magazines, and brochures in the field of scientific research on ischemic conditions, fibrosis, autoimmune diseases, organ transplantation; providing a website featuring non-downloadable electronic publications in the nature of books, magazines, and brochures in the field of related to scientific research on acute organ injuriesACTIVE—
042Providing medical and scientific research information in the field of pharmaceuticals and clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 13, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 13, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 12, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 8, 2022EX3GSOU EXTENSION 3 GRANTED—
Jul 8, 2022EXT3SOU EXTENSION 3 FILED—
Jul 8, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 13, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 11, 2022EX2GSOU EXTENSION 2 GRANTED—
Jan 11, 2022EXT2SOU EXTENSION 2 FILED—
Jan 11, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 13, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 9, 2021EX1GSOU EXTENSION 1 GRANTED—
Jul 9, 2021EXT1SOU EXTENSION 1 FILED—
Jul 9, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 12, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 17, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 17, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 28, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 15, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 14, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 14, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 14, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 22, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2020DOCKASSIGNED TO EXAMINER—
Feb 6, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 6, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance